Metraipolis › archive › dc_ab45ef7ce2a0
DNA Methylation Profiling in Melanoma: From Lesion Classification to Therapeutic Stratification — arXiv:2608.21448
- Source
- arXiv (en)
- Original
- https://arxiv.org/abs/2608.21448
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-18T10:06:26.749Z
- SHA-256 of the archived text
71358f1054a8c29e046e0f8fadf55d821c842912d1af8a531ea7f56d37fc589f- Stable URL of this page
https://metraipolis.com/documento/dc_ab45ef7ce2a0
How to cite
DNA Methylation Profiling in Melanoma: From Lesion Classification to Therapeutic Stratification — arXiv:2608.21448 — arXiv (en), https://arxiv.org/abs/2608.21448 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ab45ef7ce2a0 (Metraipolis archive dc_ab45ef7ce2a0, sha256 71358f1054a8c29e046e0f8fadf55d821c842912d1af8a531ea7f56d37fc589f)
BibTeX
@misc{dcab45ef7ce2a0,
title = {DNA Methylation Profiling in Melanoma: From Lesion Classification to Therapeutic Stratification — arXiv:2608.21448},
howpublished = {arXiv (en)},
url = {https://arxiv.org/abs/2608.21448},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ab45ef7ce2a0; sha256 71358f1054a8c29e046e0f8fadf55d821c842912d1af8a531ea7f56d37fc589f},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2608.21448. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
DNA methylation provides a stable record of cellular identity, capturing epigenetic programs that distinguish specialized cell states despite a shared genome. Because malignant transformation and tumour progression are accompanied by extensive epigenetic remodeling, we hypothesized that the methylome of melanocytic lesions contains biologically and clinically relevant information for both diagnosis and disease progression. In a cohort of 1,001 tissue samples prospectively collected across eight German university hospitals profiled using Illumina Infinium MethylationEPIC arrays, we compared machine-learning models based on selected Cytosine phosphate Guanine (CpG) methylation sites with models incorporating biology-guided features, including epigenetic age acceleration, cell type composition and copy-number variation burden. In an external test set, the best diagnostic classifier was CpG-based and distinguished melanocytic nevi, noninvasive melanoma and invasive melanoma with a macro-averaged area under the receiver operating characteristic curve of 0.919 (95% CI: 0.878 to 0.952). Notably, across CpGs most strongly hyper- and hypomethylated between NV and IM, NIM showed an intermediate methylation profile, providing a molecular correlate of its diagnostic complexity. The best model for clinically relevant treatment group prediction, with AJCC stages grouped according to guideline-based management recommendations, relied on biology-guided features and achieved a macro-averaged mean absolute error of 0.627 (95% CI: 0.477 to 0.808). Together, these findings demonstrate that methylation-based models can capture both diagnostic identity and clinically relevant disease stratification, supporting DNA methylation as a promising biomarker for further validation and potential clinical translation. Tema degli esploratori: scienze della vita e salute (retro-catalogo arXiv: annunci del 2026-08-25 in q-bio.GN). Categorie arXiv: Genomics (q-bio.GN) ; Machine Learning (cs.LG). Pagina del lavoro: https://arxiv.org/abs/2608.21448 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina. Letto il 2026-10-18T09:58:09.606Z dalla pagina https://arxiv.org/catchup/q-bio.GN/2026-08-25?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).